CTI BioPharma Corp.
CTIC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $689 | $223 | $229 | $92 |
| - Cash | $30 | $65 | $40 | $31 |
| + Debt | $50 | $51 | $5 | $12 |
| Enterprise Value | $709 | $209 | $194 | $73 |
| Revenue | $54 | $0 | $0 | $3 |
| % Growth | – | – | -100% | – |
| Gross Profit | $50 | -$0 | -$4 | $3 |
| % Margin | 93.5% | – | – | 100% |
| EBITDA | -$80 | -$95 | -$51 | -$37 |
| % Margin | -148% | – | – | -1,118.8% |
| Net Income | -$91 | -$100 | -$53 | -$42 |
| % Margin | -168.8% | – | – | -1,265.1% |
| EPS Diluted | -0.79 | -1.11 | -0.74 | -0.73 |
| % Growth | 28.8% | -50% | -1.4% | – |
| Operating Cash Flow | -$81 | -$85 | -$42 | -$28 |
| Capital Expenditures | -$25 | $0 | -$0 | $0 |
| Free Cash Flow | -$106 | -$85 | -$42 | -$28 |